Ryan Williams: This Article Brings to Light The Complexity of PRP…
Ryan Williams, Physician Assistant at BHS Orthopedic Associates, shared on LinkedIn about a recent article by Benjamin B. Rothrauff et al, published in The American Journal of Sports Medicine:
”This article brings to light the complexity of PRP on more than the most popular topic, platelet dose.
The authors highlight patient specific impact, biologic composition, preparation, activation, ability to store PRP for future use, allogenic vs. autologous PRP, EVs, and peri-procedure optimization.
Practically, variables that can be impacted are:
1. Optimize the patient (address comorbidities, nutrition, exercise, sleep, and stress).
2. Have a consistent, high quality PRP protocol.
3. Use safe, quality, and value-based energy (not mentioned in the article), exercise (BFR), pharmaceutical and nutraceutical tools to enhance the patient and the composition of the PRP.
I’m curious of others real-world experience with pre-blood draw exercise and BFR, using a senolytic (dasatinib and quercetin, fisetin, astragalus/TA-65, etc.) or losartan (or any ARB) and any other optimization strategies.
I’ve had some patients inquire about optimizing their PRP with exercise and supplements.
I’ve had several ask about red/NIR light therapy which I encourage them to do before the procedure and continue after if they have already purchased a device (this was not mentioned in the article). ”
Title: Platelet-Rich Plasma in the Treatment of Musculoskeletal Disease in 2025 and Beyond
Authors: Benjamin B. Rothrauff, Joseph T. Featherall, Tyler J. Uppstrom, Greta Gohring, Anna-Laura Nelson, Thos A. Evans, Peter J. Millett, Matthew T. Provencher, Marc J. Philippon, Johnny Huard
Read the Full Article on The American Journal of Sports Medicine
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 20, 2026, 17:47Julie Rayes: Commenting on a Seminal NEJM Study Solving the Mystery of VITT
-
Mar 20, 2026, 17:45William Tembo: Advancing Stroke Care by Validating Acute Ischemic Treatment
-
Mar 20, 2026, 17:37Renjith Vijayakumar Selvarani: New Nanoparticle Approach Clears Brain Plaque and Restores Memory
-
Mar 20, 2026, 17:35Bawan Ahmed: New Evidence May Shift DOAC Choice in Acute DVT Management
-
Mar 20, 2026, 17:17Angelo Cascio Rizzo: CTA-Based Plaque RADS Improves Risk Stratification in ESUS
-
Mar 20, 2026, 17:09Clinical Practice Guidelines for Platelet Transfusion in Non-Surgical and Non-Traumatic Settings – CEBaP
-
Mar 20, 2026, 17:07The Rich Heterogeneity of Platelets and Its Vital Shifts Across Disease States – RPTH
-
Mar 20, 2026, 17:05Pierre Fontana: Launching the European Interuniversity Certificate in Clinical Haemostasis
-
Mar 20, 2026, 16:49Wolfgang Miesbach: A Pivotal Step Forward for Patients with von Willebrand Disease Across All Subtypes